System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Letter Ppublish

PubMed: 42225107 DOI: 10.1016/S1470-2045(26)00180-4

On the survival benefit from sentinel node biopsy for melanoma.

Lancet Oncol 27(6):e274

Authors: Dirk J Grunhagen, Edmund K Bartlett, Roger Olofsson Bagge, Stefan Suciu, Alexander C J van Akkooi

Affiliations

  • Department of Surgical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, Netherlands.
  • Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
  • Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Melanoma Institute Australia, Sydney, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia; Department of Melanoma Surgical Oncology, Institute of Academic Surgery, Royal Prince Alfred Hospital, Sydney, NSW 2065, Australia.

MeSH

Melanoma, Neoplasms, Biopsy